toxic encephalopathy
toxic encephalopathy
Explore linked clinical trials. Standard reference: MONDO:000552729 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing DCog Short for Neurotoxicity in CAR-T | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, nervous system disorder, poisoning, toxic encephalopathy | Recruiting | Not applicable | 2026-10-08 | NCT07403812 | |
| Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma | Chemically-Induced Disorders, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, oligodendroglioma, poisoning, primitive neuroectodermal tumor, toxic encephalopathy | Active, not recruiting | Phase 3 | 2026-10-05 | NCT00978458 | |
| Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire | Arsenic Poisoning, Chemically-Induced Disorders, Heavy Metal Poisoning, Nervous System, Infections, Water-related Diseases, Waterborne Diseases, nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Not applicable | 2026-09-28 | NCT07103356 | |
| Preventox - a Digital Intervention for Patients With Intoxications in Intensive Care | Alcohol-Induced Disorders, Nervous System, Chemically-Induced Disorders, alcohol withdrawal delirium, alcohol-induced disorders, alcohol-related disorders, nervous system disorder, poisoning, psychiatric disorder, substance withdrawal syndrome, substance-related disorder, toxic encephalopathy | Not yet recruiting | Not applicable | 2026-09-23 | NCT07819500 | |
| A Study to Compare the Long-term Outcomes After Two Different Anaesthetics | Chemically-Induced Disorders, nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Phase 3 | 2026-09-10 | NCT03089905 | |
| rTMS as an Intervention for Levodopa-induced Dyskinesia | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Dyskinesias, Neurologic Manifestations, Nutritional and Metabolic Diseases, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, drug-induced dyskinesia, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, poisoning, proteostasis deficiencies, synucleinopathy, toxic encephalopathy | Recruiting | Not applicable | 2026-08-27 | NCT06570824 | |
| Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery | Chemically-Induced Disorders, injury, nervous system disorder, poisoning, radiation injury, toxic encephalopathy | Recruiting | Not stated | 2026-08-18 | NCT07767981 | |
| Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning | Chemically-Induced Disorders, nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Not stated | 2026-08-18 | NCT06798142 | |
| Delayed Toxicities Post-CAR-T | Blood Protein Disorders, Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, nervous system disorder, plasma cell neoplasm, poisoning, toxic encephalopathy, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-08-10 | NCT07665307 | |
| Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma | B-cell neoplasm, Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Inflammation, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Phase 1 | 2026-07-31 | NCT03696784 | |
| Atamparib in Patients With Advanced Solid Tumors | Chemically-Induced Disorders, basal ganglia disorder, brain disorder, central nervous system disorder, nervous system disorder, neuroleptic malignant syndrome, poisoning, toxic encephalopathy | Recruiting | Phase 1 / Phase 2 | 2026-07-29 | NCT07374419 | |
| Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm, nervous system disorder, poisoning, toxic encephalopathy | Recruiting | Not applicable | 2026-07-28 | NCT07173166 | |
| A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Signs and Symptoms, central nervous system disorder, drug-induced akathisia, drug-induced dyskinesia, movement disorder, nervous system disorder, poisoning, tardive dyskinesia, toxic encephalopathy | Not yet recruiting | Not stated | 2026-07-21 | NCT07715994 | |
| Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer | Chemically-Induced Disorders, Confusion, Hemic and Lymphatic Diseases, Neoplasms by Site, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cognitive disorder, delirium, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, nervous system disorder, poisoning, psychiatric disorder, toxic encephalopathy | Active, not recruiting | Phase 2 | 2026-07-17 | NCT01949662 | |
| A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity | Chemically-Induced Disorders, nervous system disorder, poisoning, toxic encephalopathy | Recruiting | Not stated | 2026-07-16 | NCT06144151 | |
| Strong Heart Water Study | Arsenic Poisoning, Chemically-Induced Disorders, Heavy Metal Poisoning, Nervous System, nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Not applicable | 2026-05-12 | NCT03725592 | |
| Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy | Cancer of Gastrointestinal Tract, Cancer of Urinary Tract, Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, head and neck cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, nervous system disorder, poisoning, respiratory system disorder, respiratory tract neoplasm, skin disorder, toxic encephalopathy, urinary system disorder | Recruiting | Not applicable | 2026-04-30 | NCT07558447 | |
| Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy | Chemically-Induced Disorders, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, peripheral neuropathy, poisoning, toxic encephalopathy | Recruiting | Not applicable | 2026-04-22 | NCT07095998 | |
| To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity | Chemically-Induced Disorders, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Not stated | 2026-04-14 | NCT02481336 | |
| Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors | Chemically-Induced Disorders, nervous system disorder, poisoning, toxic encephalopathy | Recruiting | Not stated | 2026-01-28 | NCT07357636 | |
| BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients | Bacterial Infections and Mycoses, Chemically-Induced Disorders, Clostridium infectious disease, Foodborne Diseases, Infections, bacterial infectious disease, botulism, gram-positive bacterial infections, nervous system disorder, neuromuscular disease, neuromuscular junction disease, poisoning, toxic encephalopathy | Enrolling by invitation | Phase 4 | 2026-01-16 | NCT02051062 | |
| Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder, poisoning, toxic encephalopathy | Active, not recruiting | Early phase 1 | 2026-01-08 | NCT04514029 | |
| Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) | Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Cognitive Dysfunction, Drug-Related Side Effects and Adverse Reactions, cognitive disorder, nervous system disorder, poisoning, psychiatric disorder, toxic encephalopathy | Enrolling by invitation | Phase 3 | 2025-08-12 | NCT06950190 | |
| Chemotherapy Induced Peripheral Neurotoxicity (CIPN): Why Should we Care | Chemically-Induced Disorders, nervous system disorder, poisoning, toxic encephalopathy | Recruiting | Not stated | 2025-07-29 | NCT04986891 | |
| Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis | Bacterial Infections and Mycoses, Chemically-Induced Disorders, Clostridium infectious disease, Foodborne Diseases, Infections, bacterial infectious disease, botulism, gram-positive bacterial infections, nervous system disorder, neuromuscular disease, neuromuscular junction disease, poisoning, toxic encephalopathy | Recruiting | Phase 3 | 2024-11-20 | NCT05990881 |